Home » Advocacy » Letters, Testimony & Comments

Letters, Testimony & Comments

Letter to Sen. Ted Kennedy
July 15, 2002
Expressing strong concerns regarding S. 812 (McCain/Schumer- Edwards/Collins)
BIO Opposes Brownback Amendment
June 14, 2002
Dear Majority Leader Daschle:      The Biotechnology Industry Organization (BIO) opposes Senator Brownback's patent amendment to S. 2600, the Terrorism Risk Insurance Act of 2002, now under consideration by the U.S....
BIO's response to a two-year moratorium on cloning
June 14, 2002
Dear Senator Hatch:      I read in the Washington Post that Senators are considering a two-year moratorium on somatic cell nuclear transfer (SCNT). On behalf of the Biotechnology Industry Organization (BIO), an...
Letter to Majority Leader Daschle
June 14, 2002
The Honorable Thomas A. Daschle 509 Hart Senate Office Building Washington, DC 20510 Dear Majority Leader Daschle:      The Biotechnology Industry Organization (BIO) opposes Senator Brownback's patent amendment...
PDUFA Final Goals
June 4, 2002
Letter from HHS Secretary Tommy Thompson
Dorgan Amendment, Letter opposing to Sen. Daschle
May 21, 2002
BIO Supports Wyden NETGuard Legislation
May 15, 2002
Letter to Senator Ron Wyden (May 15, 2002).
Policy Matters: Key Political and Regulatory Issues Affecting the Biotechnology Industry
May 9, 2002
Good morning, ladies and gentlemen. My name is Carl Feldbaum, and I'm here today to talk about the major political and regulatory forces shaping the biotechnology industry. The impact of those forces is large. Policy matters for this young and...
Stem cell research
May 7, 2002
Dan Eramian, Vice President, Communications, Biotechnology Industry Organization (BIO) I don't know a better way to start a fight than to bring up politics or religion. Of course, my organization like other trade groups in Washington,...
Supporting the Passage of Trade Promotion Authority Without Accompanying Amendments
May 6, 2002
Letter, United States Senate
Patent Law Harmonization: Letter to James Rogan
May 6, 2002
Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
PTO response to Carl Feldbaum on International Patent Harmonization Efforts
May 6, 2002
Letter to James Rogan, Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
May 6, 2002
Report on the State of the Industry
April 29, 2002
Ladies and gentlemen, good afternoon. I'm Carl Feldbaum, president of the Biotechnology Industry Organization, and I'm here today to report on the state of our industry, which is, from a big picture perspective, excellent. Biotechnology...
BIO's comments regarding the NPRM that proposes changes to the HIPAA privacy regulation
April 25, 2002
Robinsue Frohboese, Ph.D. Acting Director, Office for Civil Rights U.S. Department of Health and Human Services Attention: Privacy 2, Room 425A Hubert H. Humphrey Building 200 Independence Avenue, S.W. Washington, D.C. 20201   Re:...
Testimony of Charles A. Johnson, MBChB
April 23, 2002
Good morning, Mr. Chairman and Members of the Committee. My name is Dr. Charles Johnson. I am Associate Director of Specialty Biotherapeutics at Genentech, Inc., a leading biotechnology company headquartered in South San Francisco, California. I...
Testimony of Charles A. Johnson, MBChB on behalf of the BIO before the Senate Committee on Health, Education, Labor and Pensions
April 23, 2002
Good morning, Mr. Chairman and Members of the Committee. My name is Dr. Charles Johnson. I am Associate Director of Specialty Biotherapeutics at Genentech, Inc., a leading biotechnology company headquartered in South San Francisco, California. I...
Testimony of Michael J. Werner, Esq. before the Committee on Health, Education, Labor, and Pensions, hearing on Medical Privacy
April 16, 2002
Bayh-Dole and Technology Transfer
April 11, 2002
Summary The biotechnology industry is the most research and development intensive and capital-focused industry in the world. The United States currently leads the world in the area of biotechnology because U.S. patent laws and legislation such as...
BIO letter to the editor of the Washington Post clarifying the Bayh-Dole Act
March 29, 2002